InvestorsHub Logo
Followers 30
Posts 1939
Boards Moderated 0
Alias Born 01/11/2011

Re: None

Monday, 07/18/2011 11:51:16 AM

Monday, July 18, 2011 11:51:16 AM

Post# of 409055
From HITK 10k:

The Company is currently evaluating several strategies to preserve its Lodrane® franchise. These opportunities include filing a 505(b)(2) filing with the FDA to receive approval for the current Lodrane® product or in-licensing a similar product. A filing with the FDA could lead to either a prescription or OTC product depending on the requested indication and data provided in the filing.

Read more: http://www.faqs.org/sec-filings/110712/HI-TECH-PHARMACAL-CO-INC_10-K/#ixzz1STMOSasZ


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News